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INTRODUCTION
Kayexalate (sodium polystryrene sulfonate, SPS) is a cation-
exchange resin often administered orally or as an enema with
sorbitol to treat hyperkalemia. Colonic necrosis has been des-
cribed as a rare complication after administration of kayex-
alate in the literature (1-5). To the best of our knowledge,
this is the first histologically proven case in Korea of colonic
mucosal necrosis following Kalimate (calcium polystryrene
sulfonate), an analogue of Kayexalate. In contrast to previ-
ously reported cases, this patient was treated with Kalimate
suspended in 20% dextrose water (DW), not in sorbitol that
has been known to have a toxic effect on the mucosa rather
than Kayexalate itself (1). However this patient revealed the
same clinical manifestation and pathologic changes as patients
who showed colonic necrosis after treatment of Kayexalate
in sorbitol.
CASE REPORT
A 34-yr-old man was admitted to the hospital because of
a sudden development of headache, sweating and vomiting.
He had a history of hypertension and chronic renal failure
due to IgA nephropathy. After 3 yr of peritoneal dialysis (one
and a half years before the current admission), hemodialysis
was initiated. At the time of the patient’s visit to the emer-
gency room, his temperature was 37℃, the pulse was 95 beats
per minute, the respiratory rate was 25 breaths per minute
and the blood pressure was 162/86 mmHg. Brain computed
tomography (CT) revealed intracerebral hemorrhage in the
left thalamus and intraventricular hemorrhages in both lat-
eral ventricles, and the third and fourth ventricles. Burr hole
operation with external ventricular drainage (EVD) was per-
formed. Laboratory test performed on the admission day show-
ed uremia, creatinemia and hyperkalemia. Intermittent hemo-
dialysis was done and Kalimate (Kunwha Pharmaceutical
Co. Ltd., Korea, 10 g, b.i.d.) was administered orally. On the
ninth day of admission, the level of potassium was highly ele-
vated (8.0 mEq/L) and an electrocardiogram showed ST-seg-
ment depressions and poor R wave progression. For the man-
agement of hyperkalemia, two enemas with Kalimate prepa-
ration (30 g of Kalimate in 200 mL of 20% DW each) were
performed, and oral Kalimate (15 g, t.i.d.) had been given
for three days. Two days later, profuse hematochezia devel-
oped. A sigmoidoscopy was performed, revealing diffuse active
ulceration with mucosal necrosis and hemorrhage from the
rectum to beyond the reach of an endoscope (Fig. 1). Multi-
focal pseudomembrane formations were found. Random biop-
sies from multiple ulcerative areas were performed. 
Histologically, the colonic mucosa showed active colitis with
mucosal necrosis or ulceration. There were irregular shaped and
sized, angulated crystals with a characteristic crystalline mosaic
pattern on the mucosa and ulcer bed tissue and within the
necroinflammatory debris (Fig. 2A, B). They were basophilic
on H&E stain (Fig. 2C), blue on Diff-Quik stain (Fig. 2D)
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Colonic Mucosal Necrosis Following Administration of Calcium
Polystryrene Sulfonate (Kalimate) in a Uremic Patient
Colonic necrosis is known as a rare complication following the administration of
Kayexalate (sodium polystryrene sulfonate) in sorbitol. We report a rare case of
colonic mucosal necrosis following Kalimate (calcium polystryrene sulfonate), an
analogue of Kayexalate without sorbitol in a 34-yr-old man. He had a history of hyper-
tension and uremia. During the management of intracranial hemorrhage, hyper-
kalemia developed. Kalimate was administered orally and as an enema suspend-
ed in 20% dextrose water to treat hyperkalemia. Two days after administration of
Kalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed dif-
fuse colonic mucosal necrosis in the rectum and sigmoid colon. Microscopic exami-
nation of random colonic biopsies by two consecutive sigmoidoscopies revealed
angulated crystals with a characteristic crystalline mosaic pattern on the ulcerated
mucosa, which were consistent with Kayexalate crystals. Hematochezia subsided
with conservative treatment after a discontinuance of Kalimate administration.
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and red on acid fast stain. There were no typical histologic
features of viral infection or acute ischemic colitis, such as with-
ering crypts, stromal hyalinization or fibrin thrombi in the
vessels. Also there were no features of chronic colitis, including
inflammatory bowel disease, chronic diverticular disease-asso-
ciated colitis or chronic ischemic colitis. After the discontinu-
ance of Kalimate, conservative treatment was initiated. One
week after the initial sigmoidoscopy, a follow-up sigmoidoscopy
was performed, showing multiple scattered ulcers with slight
improvement. Random biopsies were obtained from the differ-
ent levels of the rectum, sigmoid and lower descending colon,
showing healing ulcerations with the presence of a few remain-
ing crystals (Fig. 3). Clostridium difficile (C. difficile) toxin assays
had been performed four times during the period between
endoscopic examinations and 2 weeks after the second endo-
scopy, and all were negative. Hematochezia gradually sub-
sided and disappeared, however the patient died of cardio-
vascular problems on the forty fifth day of admission.
Fig. 1. A sigmoidoscopy shows diffuse ulceration with pseudomembrane formation in the entire sigmoid colon and rectum.
Fig. 2. Microphotographs of Kalimate crystals. (A, B) Angulated crystals are seen on the colonic mucosa and admixed within necroin-
flammatory exudates (H&E stain, ×100 and ×40). The crystals are basophilic on H&E stain (C, ×1,000) and blue on Diff-Quik stain (D,
×1,000). A characteristic crystalline mosaic pattern is better demonstrated with Diff-Quick staining (D).
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DISCUSSION
Kayexalate (sodium polystryrene sulfonate) is a cation-ex-
change resin that has been widely used for the management
of hyperkalemia since the 1970s. It can be administered orally
or by nasogastric tube or instilled into the colon as an enema
preparation. Kayexalate was mixed with sorbitol, a hyper-
tonic solution to avoid constipation, fecal impaction or Kayex-
alate bezoar formation (6). Lillemoe et al. reported the first
series of five patients with uremia who had colonic necrosis
that was associated with the use of Kayexalate enema sus-
pended in sorbitol in 1987 (1). Its occurrence was reported
in approximately 1% of patients receiving Kayexalate in sor-
bitol (2), most of whom had multiple medical and/or surgi-
cal problems, especially including uremia (1-7). Clinicopatho-
logic findings of patients with Kayexalate-associated colonic
necrosis in the literature are summarized in Table 1. Most
cases of colonic necrosis after administration of Kayexalate
are diagnosed in one to several days after the last dose is given
(3). Kayexalate-associated mucosal necrosis is more common
in the lower gastrointestinal (GI) tract, however occurrences
in the upper GI tract, including the esophagus, stomach and
duodenum were also reported (2, 6). The clinical course of
colonic necrosis was sometimes fatal, while patients with upper
GI lesions rarely required surgical resection and usually recov-
ered (6). 
Kalimate is a calcium-type resin that has the same phar-
macological action as Kayexalate. Unlike Kayexalate (sodi-
um-typed resin), Kalimate does not cause an increase in serum
sodium and phosphate levels or a decrease in serum calcium
level, so it is used even for sodium-restricted patients. The
mechanism of Kayexalate in the development of colonic ne-
crosis remains unclear. However, according to the results of
experimental studies, administration of Kayexalate alone with-
out sorbitol was not found to cause any significant patholog-
ical changes (1). Therefore, sorbitol is believed to an agent
that has a toxic effect on the gastrointestinal mucosa, possi-
bly through increasing prostaglandin activity. On the other
hand, Cheng et al. (7) reported that a patient being given
Kayexalate without sorbitol showed the same pathologic fea-
tures. According to the manufacturer’s guideline for Kalimate,
a single dose of 30 g is suspended in 100 mL of water or a 2%
Fig. 3. Microphotographs of the follow up colonic biopsy. (A) Colonic mucosa shows crypt regeneration and granulation tissue formation
(H&E stain, ×40). (B) The remaining Kalimate crystal (arrow) shows a degenerative appearance with an irregular edge and surrounding
inflammatory activity (H&E stain, ×200). (C) Small fragments of crystal are embedded in the inflamed granulation tissue (H&E stain, ×400),
crystalloid appearances (arrows) of which are highlighted on Diff-Quick stain (D, ×400)
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methylcellulose solution or 5% DW. Twenty percent DW,
a hypertonic solution, has been also commonly used as a sus-
pension solution to enhance the enema effect as in this case.
It is uncertain whether the use of 20% DW as a mixing solu-
tion may play a part in the development of mucosal necro-
sis. Thus, further investigation of the role of Kayexalate itself
or different types of suspension in the development of mucos-
al necrosis seems to be necessary. 
Gastrointestinal complications in the patients who have
multiple medical or surgical problems, such as uremia, im-
munosuppression or transplantation are not uncommon. Is-
chemic colitis, opportunistic infection and antibiotic-induced
C. difficile colitis are the main differential diagnoses for patients
with bloody diarrhea (8, 9). Endoscopic findings characterized
by pseudomembrane formation, mucosal ulceration, edema
or hemorrhage as seen in this case are insufficient to differ-
entiate ischemic colitis, pseudomembranous colitis, infectious
colitis, such as Escherichia coli O157:H7 or Kayexalate-asso-
ciated mucosal necrosis. Also there can be considerable his-
tologic overlapping. Therefore, it is difficult to define the
etiology for colonic necrosis in the patients who present with
multiple medical problems and are susceptible to mucosal
injury. Combined clinical, laboratory and histologic exami-
nations are mandatory to exclude the common causes of mu-
cosal necrosis as well as to make a diagnosis of Kayexalate-
associated mucosal necrosis. However foremost, the observa-
tion of angulated crystals of Kayexalate with a characteristic
crystalline mosaic pattern is crucial to diagnose Kayexalate-
associated mucosal necrosis (2, 6). From a histological aspect,
crystals of cholestyramine (used to lower high levels of choles-
terol in the blood or to treat the itching that is associated with
a blockage of the biliary tract) have to be differentiated from
Kayexalate crystals: the former is more basophilic, opaque
without a mosaic pattern and rhomboid in shape compared
to the latter (2). The microscopic appearances of Kalimate
crystals were the same as the well-known features of Kayex-
alate crystals. 
In this patient, no evidence of systemic infection, negative
C. difficile toxin assays, no histologic features suggestive of
viral infections or ischemic colitis and the presence of exten-
sive mucosal necrosis with Kayexalate crystals help to make
a diagnosis. We think it is necessary for the clinician to be
aware of that the use of Kayexalate (or Kalimate) preparation
can be related to gastrointestinal, especially colonic mucosal
necrosis in a small subset of patients who have multiple med-
ical problems. Recognition of Kayexalate crystals is impor-
tant for pathologists in reaching a correct diagnosis. 
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